
Sam Neill has provided fans with an update on his cancer battle following his diagnosis of the rare blood cancer angioimmunoblastic T-cell lymphoma.
When chemotherapy proved ineffective in eliminating the cancer, Neill's doctor switched him to an anti-cancer drug that has successfully kept him in remission for over a year.
Neill now needs fortnightly infusions for life, although the drug's effectiveness is expected to diminish over time.
In an interview with The Herald Sun, the actor mentioned that the drug is making it increasingly difficult for him to perform everyday tasks.
"It’s just meant that every second week, it was a case of, 'Forget about the weekend'... because that would be a bit grim," he said.
"But other than that, it’s great to be alive and working and in beautiful places, like York."
Neill has been working throughout his treatment, continuing his role as a defence lawyer in the second series of The Twelve.
The New Zealand actor was on a promotional tour for Jurassic World Dominion in March 2022 when he first "experienced swollen glands". Soon after, he was diagnosed with angioimmunoblastic T-cell lymphoma.
Earlier this year, Neill released his memoir titled Did I Ever Tell You This? with his illness being a "spiral thread" through the story.
Speaking to The Guardian about it, he shared how he began writing the book during treatment, noting how his memories kept him company.
Watch the trailer for Sam Neill's new film, The Portable Door. Post continues after video.
"I found myself with nothing to do," he told the publication.
"And I’m used to working. I love working. I love going to work. I love being with people every day and enjoying human company and friendship and all these things. And suddenly I was deprived of that. And I thought, 'what am I going to do?'"
"I never had any intention to write a book," he continued.
"But as I went on and kept writing, I realised it was actually sort of giving me a reason to live and I would go to bed thinking, 'I’ll write about that tomorrow… that will entertain me."